Dominant contribution of malignant endothelial cells to endotheliopoiesis in chronic myeloid leukemia

Experimental Hematology

Volumn 37, Issue 1, 2009, Pages 87-91

  Wu, Jingyi ^a   Huang, Liang ^a   Huang, Mei ^a   Liu, Wenli ^a   Zheng, Miao ^a   Cao, Yang ^a   Liu, Yanling ^a   Zhang, Yicheng ^a   Lu, Yunping ^a   Xu, Gang ^a   Wang, Shixuan ^a   Ma, Ding ^a   Zhou, Jianfeng ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BCR ABL PROTEIN;

ADULT; ARTICLE; BONE MARROW; CANCER CELL; CELL ISOLATION; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIOPOIESIS; ENDOTHELIUM CELL; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HEMATOPOIESIS; HUMAN; HUMAN CELL; IMMUNOMAGNETIC SEPARATION; IMMUNOPHENOTYPING; MALE; PRIORITY JOURNAL;

ADULT; CELL SEPARATION; ENDOTHELIAL CELLS; FEMALE; GENES, ABL; HUMANS; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; MALE; MIDDLE AGED;

EID: 57549084082     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exphem.2008.08.009     Document Type: Article

References (18)

1. Choi K., Kennedy M., Kazarov A., et al. A common precursor for hematopoietic and endothelial cells. Development 125 (1998) 725-732
2. Wang L., Li L., Shojaei F., et al. Endothelial and hematopoietic cell fate of human embryonic stem cells originates from primitive endothelium with hemangioblastic properties. Immunity 21 (2004) 31-41
3. Tavassoli M. Structure and function of sinusoidal endothelium of bone marrow. Prog Clin Biol Res 59B (1981) 249-256
4. Kopp H.G., Avecilla S.T., Hooper A.T., et al. The bone marrow vascular niche: home of HSC differentiation and mobilization. Physiology (Bethesda) 20 (2005) 349-356
5. Wilson A., and Trumpp A. Bone-marrow haematopoietic-stem-cell niches. Nat Rev Immunol 6 (2006) 93-106
6. Gunsilius E., Duba H.C., Petzer A.L., et al. Evidence from a leukaemia model for maintenance of vascular endothelium by bone-marrow-derived endothelial cells. Lancet 355 (2000) 1688-1691
7. Streubel B., Chott A., Huber D., et al. Lymphoma-specific genetic aberrations in microvascular endothelial cells in B-cell lymphomas. N Engl J Med 351 (2004) 250-259
8. Rigolin G.M., Fraulini C., Ciccone M., et al. Neoplastic circulating endothelial cells in multiple myeloma with 13q14 deletion. Blood 107 (2006) 2531-2535
9. Della Porta M.G., Malcovati L., Rigolin G.M., et al. Immunophenotypic, cytogenetic and functional characterization of circulating endothelial cells in myelodysplastic syndromes. Leukemia 22 (2008) 530-537
10. Fang B., Zheng C., Liao L., et al. Identification of human chronic myelogenous leukemia progenitor cells with hemangioblastic characteristics. Blood 105 (2005) 2733-2740
11. Baldwin H.S., Shen H.M., Yan H.C., et al. Platelet endothelial cell adhesion molecule-1 (PECAM-1/CD31): alternatively spliced, functionally distinct isoforms expressed during mammalian cardiovascular development. Development 120 (1994) 2539-2553
12. Gougos A., and Letarte M. Identification of a human endothelial cell antigen with monoclonal antibody 44G4 produced against a pre-B leukemic cell line. J Immunol 141 (1988) 1925-1933
13. Prindull G. Hemangioblasts representing a functional endothelio-hematopoietic entity in ontogeny, postnatal life, and CML neovasculogenesis. Stem Cell Rev 1 (2005) 277-284
14. Wagner D.D. Cell biology of von Willebrand factor. Annu Rev Cell Biol 6 (1990) 217-246
15. Schlegelberger B., Metzke S., Harder S., et al. Classical and molecular cytogenetics of tumor cells. In: Wegner R.D. (Ed). Diagnostic Cytogenetics (1999), Springer-Verlag, New York, Berlin, Heidelberg 151-185
16. Dome B., Dobos J., Tovari J., et al. Circulating bone marrow-derived endothelial progenitor cells: characterization, mobilization, and therapeutic considerations in malignant disease. Cytometry A 73 (2008) 186-193
17. Otten J., Schultze A., Schafhausen P., et al. Blood outgrowth endothelial cells from chronic myeloid leukemia patients are BCR/ABL1 negative. Br J Haematol 142 (2008) 115-118
18. Kvasnicka H.M., Thiele J., Staib P., et al. Reversal of bone marrow angiogenesis in chronic myeloid leukemia following imatinib mesylate (STI571) therapy. Blood 103 (2004) 3549-3551